Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

This study is testing whether cannabidiol (CBD) — a compound derived from cannabis that does not cause a high — can reduce anxiety and behavioral symptoms in older adults with mild cognitive impairment or Alzheimer's disease. **You may be eligible if...** - You are between 55 and 90 years old - You have been diagnosed with probable Alzheimer's disease or mild cognitive impairment (MCI) - You are experiencing clinically significant anxiety or behavioral symptoms - You score between 15 and 30 on the MMSE (a standard memory and thinking test) - You have a caregiver who spends at least 10 hours per week with you and can attend all study visits - You and your caregiver are fluent in English **You may NOT be eligible if...** - You have serious or unstable heart, liver, kidney, lung, or neurological disease that could confound the study - You are currently taking medications that might interact with CBD - Your caregiver is unable to participate in all required visits Talk to your doctor to see if this trial is right for you.